| For Practicing Oncologists |
  See all
 | Articles: Myeloproliferative Dz |
The Emperors New Clothes or the Current Practice of Clinical Trials for Multiple Myeloma in the USA
Cancer Investigation, 05/22/08
Bortezomib, doxorubicin and dexamethasone (PAD) front-line treatment of multiple myeloma: updated results after long-term follow-up
British Journal of Haematology, 05/21/08
Eight-year median survival in multiple myeloma after total therapy 2: roles of thalidomide and consolidation chemotherapy in the context of total therapy
British Journal of Haematology, 05/21/08
 | | Sponsor |
The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells
British Journal of Haematology, 05/21/08
Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma
Leukemia, 05/21/08
The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features
Leukemia, 05/21/08
Epigenetic Silencing of the Tetraspanin CD9 during Disease Progression in Multiple Myeloma Cells and Correlation with Survival
Clinical Cancer Research, 05/20/08
Farnesyltransferase inhibitors and their potential role in therapy for myelodysplastic syndromes and acute myeloid leukaemia
British Journal of Haematology, 05/20/08
p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implications
British Journal of Haematology, 05/20/08
Fatty acid synthase is a novel therapeutic target in multiple myeloma
British Journal of Haematology, 05/19/08
|
|
Receive daily email updates on Myeloproliferative Dz
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
145 Available Pages
 |
 |
| Sponsor |
|
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
 |
| Sponsor |
|
